JOHN E. KAO - 29 Dec 2025 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Issuer symbol
ALHC
Transactions as of
29 Dec 2025
Net transactions value
-$11,351,467
Form type
4
Filing time
30 Dec 2025, 16:53:27 UTC
Previous filing
12 Dec 2025
Next filing
14 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KAO JOHN E Chief Executive Officer, Director 1100 W. TOWN & COUNTRY RD., SUITE 1600, ORANGE /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao 30 Dec 2025 0001222028

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale $10,707,778 -572,437 -20% $18.71 2,267,505 29 Dec 2025 Direct F1, F2
transaction ALHC Common Stock Sale $643,689 -33,211 -1.5% $19.38 2,234,294 29 Dec 2025 Direct F1, F3
holding ALHC Common Stock 2,346,726 29 Dec 2025 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units. This transaction does not represent a discretionary trade by the reporting person.
F2 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.23 to $19.225. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.23 to $19.51. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F4 Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.